Výsledky vyhľadávania - "Chronic Disease therapy"

  1. 1
  2. 2

    Zdroj: Nat Commun
    Nature Communications, Vol 16, Iss 1, Pp 1-36 (2025)
    Christensen, S W M & GBD 2019 Acute and Chronic Care Collaborators 2025, 'Characterising acute and chronic care needs : insights from the Global Burden of Disease Study 2019', Nature Communications, vol. 16, no. 1, 4235. https://doi.org/10.1038/s41467-025-56910-x
    Cayetano Heredia Peruvian University 2025, 'Characterising acute and chronic care needs : insights from the Global Burden of Disease Study 2019', Nature Communications, vol. 16, no. 1, 4235. https://doi.org/10.1038/s41467-025-56910-x
    Nature communications
    GBD 2019 Acute and Chronic Care Collaborators 2025, 'Characterising acute and chronic care needs : insights from the Global Burden of Disease Study 2019', Nature Communications, vol. 16, no. 1, 4235. https://doi.org/10.1038/s41467-025-56910-x
    Nature Communications, vol 16, iss 1

    Popis súboru: application/pdf

  3. 3
  4. 4

    Zdroj: Health Qual Life Outcomes
    Health and Quality of Life Outcomes, Vol 23, Iss 1, Pp 1-12 (2025)
    Holm, A, Lyhnebeck, A B, Buhl, S F, Bissenbakker, K, Kristensen, J K, Møller, A, Prior, A, Kamper-Jørgensen, Z, Böcher, S, Kristensen, M A T, Waagepetersen, A, Dalsgaard, A H, Siersma, V, Guassora, A D, Brodersen, J B & on behalf MM600 trial group 2025, ' Development of a PROM to measure patient-centredness in chronic care consultations in primary care ', Health and Quality of Life Outcomes, vol. 23, no. 1, 4 . https://doi.org/10.1186/s12955-024-02327-x
    on behalf MM600 trial group 2025, 'Development of a PROM to measure patient-centredness in chronic care consultations in primary care', Health and Quality of Life Outcomes, vol. 23, no. 1, 4, pp. 4. https://doi.org/10.1186/s12955-024-02327-x

    Popis súboru: application/pdf

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Zdroj: BMC Med Inform Decis Mak
    BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-21 (2024)
    BMC Medical Informatics and Decision Making, 24
    BMC Medical Informatics and Decision Making

    Popis súboru: application/pdf

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Predmety: ψ–Hamzah, Type 1 Diabetes, T1D, autoimmune disease, β-cells, insulin, glucose metabolism, autoimmune response, immune tolerance, nanovaccine, injectable drug, oral nano-drug, lipid nanoparticles, mRNA technology, fractional calculus, biological quantum field theory, mathematical modeling, immune system dynamics, immune modulation, β-cell regeneration, diabetes cure, nanomedicine, immunotherapy, immune suppression, immune activation, Treg cells, CpG, IL-10, TGF-β1, PLGA nanoparticles, immunomodulation, quantum field theory, fractional derivatives, complex integral, biosignaling, cell therapy, immune cells, therapeutic agents, molecular therapy, therapeutic nanocarriers, quantum biology, regenerative medicine, autoimmune treatment, targeted drug delivery, gene delivery, nanotechnology, PEGylation, immunological treatment, immune tolerance induction, β-cell function, diabetes management, nanostructures, immune suppression, immune activation, regenerative therapeutics, immunomodulatory therapy, β-cell survival, chronic autoimmune diseases, mRNA vaccines, nanoformulations, immune checkpoint inhibitors, synthetic biology, cellular therapy, chronic inflammation, cellular regeneration, tissue engineering, bioinformatics, systems biology, molecular biology, clinical translation, preclinical trials, regulatory guidelines, WHO, FDA, EMA, clinical trials, autoimmune suppression, immune system restoration, drug development, immune therapeutics, nanocarrier systems, T1D prevention, therapeutic vaccines, clinical efficacy, health innovation, biopharmaceuticals, diabetes research, computational models, mathematical simulations, molecular modeling, immune therapies, disease control, insulin production, autoimmunity, lipid vesicles, immune cell dynamics, autoantibodies, nanomaterials, regulatory approval, clinical research, immune memory, nanoencapsulation, quantum mechanics, regenerative therapy, cytokine modulation, cytokine therapy, immune surveillance, autoimmune modulation, immune cell trafficking, β-cell protection, chronic autoimmune conditions, nanovector vaccines, T1D pathogenesis, immune checkpoint therapy, cytokine release, therapeutic antibodies, T1D remission, immune system reset, immune system homeostasis, chronic disease therapy, β-cell autoimmunity, immune tolerance therapy, nanobiotechnology, disease remission, molecular immunology, cell signaling, experimental diabetes models, therapeutic nanoparticles, diabetes prevention, personalized medicine, autoimmune therapy, immune engineering, novel therapies, lipid-based vaccines, advanced therapeutics, clinical pharmacology, T-cell modulation, systemic diseases, pharmaceutical biotechnology, diabetes pathophysiology, personalized therapeutics, precision medicine, quantum immunology, fractional immuno-dynamics, nanoparticle drug delivery, bio-electronic energy, immune chaos, unstable immune network, regenerative β-cells, immune checkpoint therapy, immune chaos modeling, autoimmune reversal, insulin independence, immune programming, nanomedicine vaccines, nanoparticle encapsulation, immune phase oscillation, genetic reprogramming, cytokine suppression, autoimmune shut-down, T-cell reset, immune homeostasis, immune chaos stabilization, chronic illness cure, immune tolerance stability, β-islet regeneration, pancreatic stem cells, immune tolerance pathways, autoimmune suppression drug, immune reset nanomedicine, nanoparticle-based therapy, nanostructured vaccines, autoimmune eradication, diabetes reversal, nanotechnology-driven cure, biological quantum therapy, regenerative pharmacology, immune nanoengineering, nano-enabled cure, systemic autoimmune regulation, clinical nanomedicine, advanced drug delivery, non-invasive diabetes cure, bio-quantum vaccine, therapeutic nanodrug, quantum–immunological model, fractional bio-mathematics, molecular quantum medicine, experimental diabetes cure, quantum regenerative system, immune quantum dynamics, β-cell stability, fractal immunology, computational nanomedicine, nanoscience in diabetes, clinical-grade nanoformulation, immune chaos fractals, immune instability correction, β-cell immune protection, nano-biophysics, immune quantum oscillations, regenerative β-cell therapy, nanotechnology in T1D, systemic autoimmune correction, T1D cure simulation, next-generation nanomedicine, nano-enabled autoimmune therapy, immune chaos suppression, immune modulation nanoparticles, bio-nano therapy, β-cell quantum regeneration, nano-based drug development, autoimmune control, immune resilience therapy, immune chaos eradication, systemic bio-reprogramming, nano-immune reprogramming, biofield modulation, immuno-fractal modeling, quantum–fractional dynamics, autoimmune reversal model, insulin-free treatment, immune chaos cure, nanotechnology-based immunotherapy, clinical quantum pharmacology, advanced immune engineering, autoimmune vaccine therapy, nanomedicine revolution, systemic cure for T1D, fractal-based therapy, β-cell rejuvenation, permanent diabetes cure, immune reprogramming nanoparticles, T-cell immune tolerance, immune quantum regulation, autoimmunity cure, regenerative immunology, nanomedicine approach, ψ-field therapy, quantum-driven cure, diabetes-free future, autoimmune eradication nanomedicine, clinical trial nanotherapy, immune nanomodulation, β-cell cure system, next-gen diabetes treatment, autoimmune chaos management, T1D definitive cure

  18. 18
  19. 19

    Prispievatelia: Sunghoon Kim Jong-ick Whang Ho Jung Kang a ďalší

    Zdroj: Plastic & Reconstructive Surgery. 145:723-733

  20. 20